Clinical Trial Update: Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating radiation therapy with Paclitaxel and Carboplatin in high-risk endometrial cancer was terminated; results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Adenocarcinoma
• Endometrial Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Radiation therapy

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Endometrial Adenocarcinoma, Stage IA Uterine Corpus Cancer | Phase 2 | Status: TERMINATED | Results posted: 2023-10-26